Michael Ashford

DelveInsight projects that the Alzheimer’s disease market will undergo rapid evolution over the next decade, driven by rising disease prevalence, growing awareness, and the advancement of a robust clinical pipeline. The anticipated launch of therapies across multiple stages of development is expected

According to DelveInsight’s latest report, “Paroxysmal Nocturnal Hemoglobinuria Market Insights, Epidemiology, and Market Forecast – 2034,” the global Paroxysmal Nocturnal Hemoglobinuria (PNH) market is expected to witness notable expansion during the forecast period. The report provides a comprehensive analysis of disease epidemiology,

(Las Vegas, Nevada, United States) According to DelveInsight’s latest evaluation, the global bispecific antibody pipeline includes more than 180 active companies collectively developing over 250 bispecific antibody–based therapeutic candidates. The pipeline analysis provides a detailed overview of clinical trials, therapeutic approaches, mechanisms

The Complicated Urinary Tract Infection (cUTI) market is expected to witness substantial growth through 2034, supported by rising disease prevalence, increasing antimicrobial resistance (AMR), and a robust late-stage antibiotic pipeline, according to DelveInsight’s Complicated Urinary Tract Infection Market Insights, Epidemiology, and Forecast

The global clinical trial support services market is set to witness sustained growth, driven by the rising burden of chronic diseases, increasing clinical trial volumes, and expanding pharmaceutical and biotechnology R&D pipelines. According to DelveInsight, the market is projected to reach USD

According to DelveInsight’s assessment, the global medical drones market is set for robust growth, supported by multiple converging factors that are creating a favorable environment for expansion. One of the primary drivers is the rising demand for rapid and reliable delivery of

According to DelveInsight’s latest report, “Dermatomyositis Market Insights, Epidemiology, and Market Forecast – 2034,” the global dermatomyositis market is expected to experience robust growth through 2034, driven by rising disease awareness, expanding diagnostic rates, and a rapidly advancing therapeutic pipeline. The report

Multiple Sclerosis Pipeline 2025: Clinical Progress, MOA, ROA, and Regulatory Advances – DelveInsight Las Vegas, Nevada, United States – DelveInsight has released its latest industry report, “Multiple Sclerosis Pipeline Insight, 2025,” delivering a comprehensive overview of the evolving Multiple Sclerosis (Multiple Sclerosis)

According to a recent DelveInsight report, the Urea Cycle Disorders (UCD) market is expected to witness substantial expansion through 2032, driven by increasing disease awareness, improved diagnostics, and a rapidly advancing therapeutic pipeline. The report, titled “Urea Cycle Disorders Market Insights, Epidemiology,